About
Cancer Diagnostics
Areas of Focus
Categories
DiagnosticsSoutheastern U.S.
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
2
As Collaborator
5
Total Enrollment
2,533
By Phase
NA: 5
By Status
COMPLETED: 5NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT06778317Collaborator
MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients with Cirrhosis
N/ANot yet recruiting
400 participants
Started: Mar 3, 2025 · Completed: Mar 3, 2031
NCT05614011Collaborator
Q-POC SARS-CoV-2 Assay COVID-19 Clinical Evaluation
NACompleted
877 participants
Started: Nov 28, 2022 · Completed: May 17, 2023
NCT05551052Lead Sponsor
CRC Detection Reliable Assessment With Blood
N/AActive, not recruiting
196 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2027
NCT05555030Lead Sponsor
COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation
NACompleted
100 participants
Started: Aug 4, 2022 · Completed: Dec 20, 2022
NCT05584176Collaborator
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
NACompleted
332 participants
Started: Dec 9, 2021 · Completed: Jan 21, 2022
Funding History (1)
D
Aug 15, 2023
Locations (1)
Headquarters
Knoxville, TN, United States
Map
Loading map...